Cancer Genetics
Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare
Sophia, which will trade on the Nasdaq, seeks to raise $100 million in an IPO, and separately announced a partnership with GE Healthcare.
Geisinger Health System Wins $3.6M NIH Grant to Study Genetics of Cancer Risk
The health system will partner with the NCI to look for new cancer risk variants in a large population biobank, in the hopes of improving screening and care.
Cancer Genetics to Sell $17.5M in Common Stock Through Direct Offering
The New Jersey-based cancer drug-discovery services provider said it had signed agreements to sell the shares to unnamed institutional investors.
Cancer Genetics to Raise $10M in Private Placement
The firm plans to use the net proceeds for general corporate purposes, including working capital and capital expenditures.
Cancer Genetics Q3 Revenues Down 24 Percent
The drug discovery and preclinical oncology services provider attributed the revenue decline to the impact of the SARS-CoV-2 pandemic on its customers.
Aug 24, 2020
Cancer Genetics to Acquire Organoid Startup Stemonix
Aug 14, 2020
Cancer Genetics Q2 Revenues Drop 5 Percent
Jun 25, 2020
Cancer Genetics Q1 Revenues Drop 22 Percent
Jun 1, 2020
Cancer Genetics Q4 2019 Revenues Up 12 Percent
Aug 20, 2019
Cancer Genetics Posts 15 Percent Rise in Q2 Revenues
May 21, 2019
Cancer Genetics Q1 Revenues Fall 11 Percent
Apr 16, 2019
Cancer Genetics Q4 Revenues Down 9 Percent
Jan 10, 2019
Cancer Genetics Targets $3M in Public Offering
Nov 20, 2018